Craig B. Thompson - 03 Jan 2023 Form 4 Insider Report for CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)

Role
Director
Signature
/s/ Craig B. Thompson, M.D.
Issuer symbol
CRL
Transactions as of
03 Jan 2023
Net transactions value
+$129,293
Form type
4
Filing time
04 Jan 2023, 20:35:48 UTC
Previous filing
14 Dec 2022
Next filing
17 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRL Common Stock Award $0 +244 $0.000000 244 03 Jan 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CRL Stock Options (Right to Buy) Award $129,293 +592 $218.40 592 03 Jan 2023 Common Stock 592 $218.40 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of 244 unvested restricted stock units that vest on 1/03/2024.
F2 The Stock Options become exercisable 1/03/2024.